May 2010 Briefing - Radiology
Here are what the editors at HealthDay consider to be the most important developments in Radiology for May 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
CT Contrast Agents May Cause Delayed Adverse Reactions
FRIDAY, May 28 (HealthDay News) -- Delayed adverse reactions (DARs) occur more frequently in patients undergoing contrast-enhanced computed tomography (CT) than in those undergoing unenhanced CT, according to a study in the June issue of Radiology.
Breast Imaging Techniques May Enhance Cancer Detection
WEDNESDAY, May 26 (HealthDay News) -- Contrast-enhanced breast magnetic resonance imaging can detect malignancy in probably benign lesions in the accepted range for mammographically detected Breast Imaging and Reporting and Data System (BI-RADS) category 3 lesions, and mammographic digital screening offers the potential to increase the rate of invasive cancers detected on the basis of calcifications, according to two studies published in the June issue of Radiology.
New Rule Reduces Low-Yield Outpatient Imaging Exams
TUESDAY, May 25 (HealthDay News) -- A rule that prevents medical support staff from completing computerized orders for outpatient imaging exams that have a high likelihood of being negative results in fewer low-yield examinations and an increased percentage of tests ordered by clinicians themselves, according to a study in the June issue of Radiology.
With Intermediate Risk of CAD, CTCA Valuable First Test
WEDNESDAY, May 19 (HealthDay News) -- As a tool for predicting the need for invasive coronary angiography (ICA), computed tomography coronary angiography (CTCA) appears to be most useful for patients at intermediate risk of coronary artery disease and may be more useful than stress testing in that population, according to research published May 18 in the Annals of Internal Medicine.
New FDA Program Targets Misleading Drug Advertising
WEDNESDAY, May 12 (HealthDay News) -- The U.S. Food and Drug Administration has announced the launch of a new program to educate health care providers regarding their role in making certain that advertisements and promotions for prescription drugs are truthful and not misleading.
Radiation for Wilms Tumor May Affect Future Pregnancies
TUESDAY, May 11 (HealthDay News) -- Women who have had prior radiation treatment for unilateral Wilms tumor diagnosed in childhood have a higher risk of pregnancy and birth complications, according to research published online May 10 in the Journal of Clinical Oncology.
Magnetic Stimulation Found Effective for Depression
MONDAY, May 3 (HealthDay News) -- The use of daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) is likely an effective and safe option for the treatment of major depressive disorder, according to a study in the May issue of the Archives of General Psychiatry.